Bring together regulators, industry, patients, and academia to exchange perspectives on Canada’s role in global regulatory science
Highlight the latest developments in regulation, safety, labeling, trial modernization, and digital transformation
Strengthen partnerships between Health Canada, international regulators, industry leaders, and patient representatives
Provide learning opportunities across regulatory, clinical, and safety domains to expand participant knowledge and expertise
Create space for peer-to-peer exchange through plenaries, breakouts, and dedicated networking sessions
Direct access to Health Canada leadership and global regulators
Timely updates on evolving regulations, policies, and compliance frameworks
Patient-centered perspectives that put lived experience at the heart of discussions
Cutting-edge insights on AI, digital submissions, and innovative clinical research models
Opportunities to connect with diverse stakeholders across the life sciences ecosystem
Three Educational Tracks: Regulatory, Clinical, Safety and Pharmacovigilance
Track A: Regulatory
The regulatory track provides opportunities for information sharing, use cases, and best practices relating to Canada’s regulatory landscape as it applies to regulatory requirements, new developments, and innovation for life sciences R&D.
Today, modern pharmaceutical, medical device, and diagnostic products are advancing at an unprecedented speed. Sessions in this track will focus on clinical research development and operations for industry.
Our safety and pharmacovigilance track will provide a comprehensive overview of Canada’s regulatory environment in the field of clinical safety and pharmacovigilance for pharmaceutical products and medical devices.
October 16, 2025 – 10:00AM – 1:15PM ET | Virtual *Short Courses require an additional registration fee. You do not need to be registered for the forum to attend* The International Council for Harmonisation (ICH) E6 guideline is the global standard for Good Clinical Practice (GCP) in human clinical trials. The recently updated ICH E6(R3) introduces key changes aimed at enhancing trial quality, participant safety, and data integrity. This short course provides an overview of how Health Canada will align its inspection processes and compliance expectation with the revised guideline.
October 22, 2025 – 10:00AM – 2:00PM ET | Virtual *Short Courses require an additional registration fee. You do not need to be registered for the forum to attend* There is an increasing number of risk minimization programs that are implemented in Canada and elsewhere, ranging from communication to mandatory trainings and controlled distribution, amongst others. Although these programs carry enormous relevance for patients and public health, determining whether these programs are effective is methodologically challenging. Methodological and regulatory guidances are available, which must be adapted to the Canadian context.